Background and aims: The aim is to evaluate and compare the efficacy and side effects of oral and intravenous(IV) ibuprofen for treatment of PDA in preterm infants. Methods: A prospective ...

Study findings indicated a transition from IV to enteral triazole therapy as a feasible option for pediatric patients with invasive candidiasis.

According to Celltrion, STEQEYMA is expected to be marketed in the United States beginning in February 2025. DISCLAIMER: Because of the generality of this update, the information provided herein may ...